NCT00688272View on ClinicalTrials.gov

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 2, 2008

Primary Completion Date

September 25, 2008

Study Completion Date

September 25, 2008

Conditions
Purpura, Thrombocytopaenic, Idiopathic
Interventions
DRUG

Ciprofloxacin

Given 500mg BID x 6 days

DRUG

Eltrombopag

Given QD x 6 days

DRUG

Placebo

Given QD x 6 days

Trial Locations (1)

DD1 9SY

GSK Investigational Site, Dundee

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00688272 - Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag | Biotech Hunter | Biotech Hunter